| P2093 | author name string | Howard Cedar | |
| | Yehudit Bergman | |
| | Rena Levin-Klein | |
| | Chaggai Rosenbluh | |
| | Andrei Kirillov | |
| P2860 | cites work | Hydroxylation of 5-methylcytosine by TET1 promotes active DNA demethylation in the adult brain | Q24299862 |
| | E2A and IRF-4/Pip promote chromatin modification and transcription of the immunoglobulin kappa locus in pre-B cells | Q24301680 |
| | Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1 | Q24316558 |
| | Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA | Q24632387 |
| | Detection of specific sequences among DNA fragments separated by gel electrophoresis | Q25939003 |
| | Developmentally controlled and tissue-specific expression of unrearranged VH gene segments | Q28259020 |
| | Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation | Q28508217 |
| | Early B-cell factor, E2A, and Pax-5 cooperate to activate the early B cell-specific mb-1 promoter | Q28511253 |
| | Ten-Eleven-Translocation 2 (TET2) negatively regulates homeostasis and differentiation of hematopoietic stem cells in mice | Q28511594 |
| | Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies | Q28591763 |
| | Transfection Using DEAE-Dextran | Q29028334 |
| | BSAP can repress enhancer activity by targeting PU.1 function | Q33786904 |
| | Chromosomal loop anchorage of the kappa immunoglobulin gene occurs next to the enhancer in a region containing topoisomerase II sites | Q34161702 |
| | Targeted DNA demethylation and activation of endogenous genes using programmable TALE-TET1 fusion proteins | Q34376497 |
| | Induced DNA demethylation by targeting Ten-Eleven Translocation 2 to the human ICAM-1 promoter | Q34382768 |
| | Targeting of somatic hypermutation | Q34551108 |
| | V(D)J recombination: RAG proteins, repair factors, and regulation | Q34667417 |
| | The Igκ gene enhancers, E3' and Ed, are essential for triggering transcription | Q34686905 |
| | Cell cycle-dependent turnover of 5-hydroxymethyl cytosine in mouse embryonic stem cells | Q35067918 |
| | Kappa chain monoallelic demethylation and the establishment of allelic exclusion | Q35202527 |
| | A new hypersensitive site, HS10, and the enhancers, E3' and Ed, differentially regulate Igκ gene expression | Q35803016 |
| | Recognition and potential mechanisms for replication and erasure of cytosine hydroxymethylation | Q36008141 |
| | Critical roles of the immunoglobulin intronic enhancers in maintaining the sequential rearrangement of IgH and Igk loci | Q36228744 |
| | The balance between Pax5 and Id2 activities is the key to AID gene expression | Q36371814 |
| | Changes in locus-specific V(D)J recombinase activity induced by immunoglobulin gene products during B cell development | Q36376789 |
| | Important roles for E protein binding sites within the immunoglobulin kappa chain intronic enhancer in activating Vkappa Jkappa rearrangement | Q36399353 |
| | A developmentally modulated chromatin structure at the mouse immunoglobulin kappa 3' enhancer | Q36560382 |
| | The Downstream Transcriptional Enhancer, Ed, positively regulates mouse Ig kappa gene expression and somatic hypermutation | Q36713840 |
| | Meta-analysis of IDH-mutant cancers identifies EBF1 as an interaction partner for TET2. | Q37137057 |
| | The colorful history of active DNA demethylation. | Q37201774 |
| | DNMT1-interacting RNAs block gene-specific DNA methylation | Q37408576 |
| | B cell-specific and stimulation-responsive enhancers derepress Aicda by overcoming the effects of silencers | Q38348243 |
| | Effect of CpG methylation on RAG1/RAG2 reactivity: implications of direct and indirect mechanisms for controlling V(D)J cleavage | Q38351912 |
| | Deletion of the Ig kappa light chain intronic enhancer/matrix attachment region impairs but does not abolish V kappa J kappa rearrangement | Q38359938 |
| | Differential accessibility at the kappa chain locus plays a role in allelic exclusion | Q39658922 |
| | The Ig kappa 3' enhancer is activated by gradients of chromatin accessibility and protein association. | Q40455059 |
| | The importance of the 3'-enhancer region in immunoglobulin kappa gene expression | Q40524393 |
| | Pax-5 is essential for kappa sterile transcription during Ig kappa chain gene rearrangement | Q40569701 |
| | 5-Hydroxymethylcytosine is an essential intermediate of active DNA demethylation processes in primary human monocytes | Q40593350 |
| | PU.1 target genes undergo Tet2-coupled demethylation and DNMT3b-mediated methylation in monocyte-to-osteoclast differentiation | Q40617973 |
| | Chromatin structural analyses of the mouse Igkappa gene locus reveal new hypersensitive sites specifying a transcriptional silencer and enhancer | Q40722898 |
| | Dissociation of Pax-5 from KI and KII sites during kappa-chain gene rearrangement correlates with its association with the underphosphorylated form of retinoblastoma | Q40804900 |
| | The immunoglobulin kappa locus contains a second, stronger B-cell-specific enhancer which is located downstream of the constant region | Q40818245 |
| | Somatic hypermutation of immunoglobulin kappa may depend on sequences 3' of C kappa and occurs on passenger transgenes. | Q41081725 |
| | In vivo occupancy of the kappa light chain enhancers in primary pro- and pre-B cells: a model for kappa locus activation | Q41130580 |
| | Cell type-specific chromatin structure determines the targeting of V(D)J recombinase activity in vitro | Q41191663 |
| | B cell-specific demethylation: a novel role for the intronic kappa chain enhancer sequence | Q41481236 |
| | Replication-dependent loss of 5-hydroxymethylcytosine in mouse preimplantation embryos | Q41936512 |
| | A human immunoglobulin lambda locus is similarly well expressed in mice and humans | Q42944671 |
| | Immunoglobulin gene transcription is activated by downstream sequence elements | Q43904180 |
| | Epigenetic ontogeny of the Igk locus during B cell development | Q45201947 |
| | Essential roles of the kappa light chain intronic enhancer and 3' enhancer in kappa rearrangement and demethylation | Q46053556 |
| | Roles of the Ig kappa light chain intronic and 3' enhancers in Igk somatic hypermutation | Q46695145 |
| | Clonal allelic predetermination of immunoglobulin-κ rearrangement. | Q50782638 |
| | DNA sequence recognition by Pax proteins: bipartite structure of the paired domain and its binding site. | Q52222420 |
| | Allelic 'choice' governs somatic hypermutation in vivo at the immunoglobulin κ-chain locus | Q57198208 |
| | Contribution of Receptor Editing to the Antibody Repertoire | Q57198265 |
| | The Ig(kappa) enhancer influences the ratio of Ig(kappa) versus Ig(lambda) B lymphocytes | Q71535980 |
| | Pax-5 is identical to EBB-1/KLP and binds to the VpreB and lambda5 promoters as well as the KI and KII sites upstream of the Jkappa genes | Q73174934 |
| | A recombination silencer that specifies heterochromatin positioning and ikaros association in the immunoglobulin kappa locus | Q83161599 |
| P304 | page(s) | 240 | |
| P577 | publication date | 2014-05-23 | |
| P1433 | published in | Frontiers in Immunology | Q27723748 |
| P1476 | title | A novel pax5-binding regulatory element in the igκ locus | |
| P478 | volume | 5 | |